| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 14,233 | 10,200 | 11,001 | | Cost of Revenue | 10,753 | 7,454 | 7,064 | | | Gross Profit | 3,480 | 2,747 | 3,937 | | | Operating Expenses | | Research Development | 747 | 418 | 538 | | Selling General and Administrative | 9,014 | 5,561 | 6,041 | | Non Recurring | 2,922 | 1 | (507) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (9,204) | (3,233) | (2,135) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (843) | 332 | 257 | | Earnings Before Interest And Taxes | (10,047) | (2,901) | (1,879) | | Interest Expense | 323 | 39 | 356 | | Income Before Tax | (10,370) | (2,940) | (2,235) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,370) | (2,940) | (2,235) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (10,370) | (2,940) | (2,235) | | Preferred Stock And Other Adjustments | (142) |
-
|
-
| | | Net Income Applicable To Common Shares | ($10,512) | ($2,940) | ($2,235) |
|
0.51% Nasdaq 0.00%
Income Statement
